1. Zaldivar Villon MLF, de la Rocha JAL, Espinoza LR. Takayasu arteritis: recent developments. Curr Rheumatol Rep 2019;21:45.

2. Seyahi E. Takayasu arteritis: an update. Curr Opin Rheumatol 2017;29:51-6.

3. Mohammad AJ, Mandl T. Takayasu arteritis in southern Sweden. J Rheumatol 2015;42:853-8.

4. Gudbrandsson B, Molberg Ø, Garen T, Palm Ø. Prevalence, incidence, and disease characteristics of Takayasu arteritis by ethnic background: data from a large, population-based cohort resident in Southern Norway. Arthritis Care Res (Hoboken) 2017;69:278-85.

5. Watanabe Y, Miyata T, Tanemoto K. Current clinical features of new patients with Takayasu arteritis observed from cross-country research in Japan: age and sex specificity. Circulation 2015;132:1701-9.

6. Isobe M, Amano K, Arimura Y, Ishizu A, Ito S, et al. JCS 2017 Guideline on Management of Vasculitis Syndrome - Digest Version. Circ J 2020;84:299-359.

7. Renauer P, Sawalha AH. The genetics of Takayasu arteritis. Presse Med 2017;46:e179-87.

8. Facchinetti M, Pierantonio Ostuni, Gabriella Cardinale. A familial case of Takayasu arteritis: HLA-related genetic susceptibility and efficacy of anti-TNFα treatment in two Italian siblings. Int J Clin Rheumatol 2018;13:341-5.

9. Chatterjee S, Flamm SD, Tan CD, Rodriguez ER. Clinical diagnosis and management of large vessel vasculitis: Takayasu arteritis. Curr Cardiol Rep 2014;16:499.

10. Alibaz-Oner F, Aydin SZ, Direskeneli H. Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis. Clin Rheumatol 2013;32:541-6.

11. Devarasetti PK, Irlapati RV, Rajasekhar L. Pentraxin 3 is better than conventional inflammatory markers for disease activity assessment in Takayasu arteritis. Indian J Rheumatol 2019;14:21-7.

12. Devarasetti PK, Appani SK, Irlapati RVP, Rajasekhar L. SAT0364 pentraxin 3 as biomarker in assessment of disease activity in Takayasu arteritis. Ann Rheum Dis 2016;75:798.

13. Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayasu’s arteritis. Clin Exp Rheumatol 2011;29:S86-91.

14. Nair AM, Goel R, Hindhumati M, Jayakanthan K, Visalakshi J, et al. Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis. Rheumatol Int 2017;37:1643-9.

15. Goel R, Kabeerdoss J, Mohan H, Danda S, Jayaseelan V, et al. Soluble-HLA-E: a follow up biomarker in Takayasu arteritis, independent of HLA-E genotype. Int J Rheum Dis 2018;21:532-40.

16. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 2007;56:1000-9.

17. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.

18. Kim ESH, Beckman J. Takayasu arteritis: challenges in diagnosis and management. Heart 2018;104:558-65.

19. Barra L, Kanji T, Malette J, Pagnoux C; CanVasc. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: a systematic review and meta-analysis. Autoimmun Rev 2018;17:175-87.

20. Miyata T, Sato O, Koyama H, Shigematsu H, Tada Y. Long-term survival after surgical treatment of patients with Takayasu’s arteritis. Circulation 2003;108:1474-80.

21. Isobe M. Takayasu arteritis revisited: current diagnosis and treatment. Int J Cardiol 2013;168:3-10.

22. Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, et al. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation 2008;118:2738-47.

23. Fields CE, Bower TC, Cooper LT, Hoskin T, Noel AA, et al. Takayasu’s arteritis: operative results and influence of disease activity. J Vasc Surg 2006;43:64-71.

24. Zhang Y, Yang K, Meng X, Tian T, Fan P, et al. Cardiac valve involvement in Takayasu arteritis is common: a retrospective study of 1,069 patients over 25 years. Am J Med Sci 2018;356:357-64.

25. Goel R, Gribbons KB, Carette S, Cuthbertson D, Hoffman GS, et al. Derivation of an angiographically based classification system in Takayasu’s arteritis: an observational study from India and North America. Rheumatology (Oxford) 2020;59:1118-27.

26. Kihara M, Kimura K, Yakuwa H, Minamisawa K, Hayashi S, et al. Isolated left coronary ostial stenosis as the sole arterial involvement in Takayasu’s disease. J Intern Med 1992;232:353-5.

27. Lanjewar C, Kerkar P, Vaideeswar P, Pandit S. Isolated bilateral coronary ostial stenosis - an uncommon presentation of aortoarteritis. Int J Cardiol 2007;114:e126-8.

28. Lie JT. Pathology of isolated nonclassical and catastrophic manifestations of Takayasu arteritis. Int J Cardiol 1998;66 Suppl 1:S11-21.

29. Kang EJ, Kim SM, Choe YH, Lee GY, Lee KN, et al. Takayasu arteritis: assessment of coronary arterial abnormalities with 128-section dual-source CT angiography of the coronary arteries and aorta. Radiology 2014;270:74-8.

30. Cipriano PR, Silverman JF, Perlroth MG, Griepp RB, Wexler L. Coronary arterial narrowing in Takayasu’s aortitis. Am J Cardiol 1977;39:744-50.

31. Amano J, Suzuki A. Coronary artery involvement in Takayasu’s arteritis. Collective review and guideline for surgical treatment. J Thorac Cardiovasc Surg 1991;102:554-60.

32. Águeda AF, Monti S, Luqmani RA, Buttgereit F, Cid M, et al. Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis. RMD Open 2019;5:e001020.

33. Keser G, Direskeneli H, Aksu K. Management of Takayasu arteritis: a systematic review. Rheumatology 2014;53:793-801.

34. Misra DP, Wakhlu A, Agarwal V, Danda D. Recent advances in the management of Takayasu arteritis. Int J Rheum Dis 2019;22 Suppl 1:60-8.

35. Tombetti E, Manfredi A, Sabbadini MG, Baldissera E. Management options for Takayasu arteritis. Expert Opin Orphan Drugs 2013;1:685-93.

36. Weaver FA, Yellin AE, Campen DH, Oberg J, Foran J, et al. Surgical procedures in the management of Takayasu’s arteritis. J Vasc Surg 1990;12:429-39.

37. Son JW, Koh KK, Dang Q, Choi IS, Shin EK. Recurrent restenosis following stent and rotational atherectomy of coronary artery stenosis in Takayasu’s arteritis. Int J Cardiol 1998;65:295-300.

38. Jung JH, Lee YH, Song GG, Jeong HS, Kim JH, et al. Endovascular versus open surgical intervention in patients with Takayasu’s arteritis: a meta-analysis. Eur J Vasc Endovasc Surg 2018;55:888-99.

39. Ueno M. Antiplatelet therapy in the treatment of Takayasu arteritis. Circ J 2010;74:1079-80.

40. Ueda H, Ito I, Saito Y. Studies on arteritis, with special reference to pulseless disease and its diagnosis. Naika 1965;15:239-56.

41. Yang Y, Tian T, Yang K, Zhang Y, Meng X, et al. Outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with Takayasu arteritis. Int J Cardiol 2017;241:64-9.

42. Emaminia A, Amirghofran AA. Complete occlusion of the left main coronary artery ostium in Takayasu arteritis. J Thorac Cardiovasc Surg 2008;135:695-6.

43. Yuan SM, Lin HZ. Coronary artery involvements in Takayasu arteritis: systematic review of reports. Gen Thorac Cardiovasc Surg 2020; doi: 10.1007/s11748-020-01378-3.

44. Endo M, Tomizawa Y, Nishida H, Aomi S, Nakazawa M, et al. Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis. J Thorac Cardiovasc Surg 2003;125:570-7.

45. Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, et al. Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J 1977;93:94-103.

46. Seko Y, Minota S, Kawasaki A, Shinkai Y, Maeda K, et al. Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu’s arteritis. J Clin Invest 1994;93:750-8.

47. Takeda N, Takahashi T, Seko Y, Maemura K, Nakasone H, et al. Takayasu myocarditis mediated by cytotoxic T lymphocytes. Intern Med 2005;44:256-60.

48. Noel N, Butel N, Le Hoang P, Koskas F, Costedoat-Chalumeau N, et al. Small vessel involvement in Takayasu’s arteritis. Autoimmun Rev 2013;12:355-62.

49. Lee GY, Jang SY, Ko SM, Kim EK, Lee SH, et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center. Int J Cardiol 2012;159:14-20.

50. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl 1992;7:11-7.

51. Sharma BK, Jain S, Radotra BD. An autopsy study of Takayasu arteritis in India. Int J Cardiol 1998;66:S85-90.

52. Toledano K, Guralnik L, Lorber A, Ofer A, Yigla M, et al. Pulmonary arteries involvement in Takayasu’s arteritis: two cases and literature review. Semin Arthritis Rheum 2011;41:461-70.

53. Yang J, Peng M, Shi J, Zheng W, Yu X. Pulmonary artery involvement in Takayasu’s arteritis: diagnosis before pulmonary hypertension. BMC Pulm Med 2019;19:225.

54. Jervell A. Pulseless disease. Am Heart J 1954;47:780-4.

55. Soto ME, Espinola-Zavaleta N, Ramirez-Quito O, Reyes PA. Echocardiographic follow-up of patients with Takayasu’s arteritis: five-year survival. Echocardiography 2006;23:353-60.

56. Yoshida M, Watanabe R, Ishii T, Machiyama T, Akita K, et al. Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience. Int J Rheum Dis 2016;19:87-94.

57. Luo F, Zhou XL, Li JJ, Hui RT. Inflammatory response is associated with aortic dissection. Ageing Res Rev 2009;8:31-5.

58. Shirai T, Hilhorst M, Harrison DG, Goronzy JJ, Weyand CM. Macrophages in vascular inflammation--from atherosclerosis to vasculitis. Autoimmunity 2015;48:139-51.

59. Wang Y, Wu B, Dong L, Wang C, Wang X, et al. Circulating matrix metalloproteinase patterns in association with aortic dilatation in bicuspid aortic valve patients with isolated severe aortic stenosis. Heart Vessels 2016;31:189-97.

60. Kaku Y, Aomi S, Tomioka H, Yamazaki K. Surgery for aortic regurgitation and aortic root dilatation in Takayasu arteritis. Asian Cardiovasc Thorac Ann 2015;23:901-6.

61. Miyata T, Sato O, Deguchi J, Kimura H, Namba T, et al. Anastomotic aneurysms after surgical treatment of Takayasu’s arteritis: a 40-year experience. J Vasc Surg 1998;27:438-45.

62. Bougioukas I, Mikroulis D, Popov AF, Bougioukas G. Re-do aortic operation in a young patient for aggressive Takayasu’s arteritis. J Cardiothorac Surg 2012;7:9.

63. Matsuura K, Ogino H, Kobayashi J, Ishibashi-Ueda H, Matsuda H, et al. Surgical treatment of aortic regurgitation due to Takayasu arteritis: long-term morbidity and mortality. Circulation 2005;112:3707-12.

64. Adachi O, Saiki Y, Akasaka J, Oda K, Iguchi A, et al. Surgical management of aortic regurgitation associated with Takayasu arteritis and other forms of aortitis. Ann Thorac Surg 2007;84:1950-4.

Vessel Plus
ISSN 2574-1209 (Online)
Follow Us


All published articles are preserved here permanently:


All published articles are preserved here permanently: